146 related articles for article (PubMed ID: 35752822)
1. Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations.
Kim IE; Kim DD; Kim S; Ma S; Jang TL; Singer EA; Ghodoussipour S; Kim IY
BMC Urol; 2022 Jun; 22(1):91. PubMed ID: 35752822
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
5. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
[TBL] [Abstract][Full Text] [Related]
6. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
[TBL] [Abstract][Full Text] [Related]
7. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
8. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
[TBL] [Abstract][Full Text] [Related]
9. Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening.
Banerji JS; Wolff EM; Massman JD; Odem-Davis K; Porter CR; Corman JM
J Urol; 2016 Jan; 195(1):66-73. PubMed ID: 26254722
[TBL] [Abstract][Full Text] [Related]
10. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
11. Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience.
Seetharam Bhat KR; Moschovas MC; Onol FF; Sandri M; Rogers T; Roof S; Rocco B; Patel VR
BJU Int; 2020 Jun; 125(6):884-892. PubMed ID: 32173990
[TBL] [Abstract][Full Text] [Related]
12. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
[TBL] [Abstract][Full Text] [Related]
13. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
14. State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
Vetterlein MW; Dalela D; Sammon JD; Karabon P; Sood A; Jindal T; Meyer CP; Löppenberg B; Sun M; Trinh QD; Menon M; Abdollah F
Urology; 2018 Feb; 112():56-65. PubMed ID: 29056579
[TBL] [Abstract][Full Text] [Related]
15. Reduced cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer: A population-based retrospective cohort study.
Song P; Yang B; Peng Z; Zhou J; Ren Z; Fang K; Yang L; Wang L; Dong Q
Int J Surg; 2020 Apr; 76():64-68. PubMed ID: 32109649
[TBL] [Abstract][Full Text] [Related]
16. The current state of prostate-specific antigen testing.
Lewis R; Hornberger B
JAAPA; 2016 Sep; 29(9):51-3. PubMed ID: 27575906
[TBL] [Abstract][Full Text] [Related]
17. Changes observed in prostate biopsy practices in an inner city hospital with a high risk patient population following the 2012 uspstf psa screening recommendations.
Tam AW; Khusid J; Inoyatov I; Becerra AZ; Davila J; Chouhan JD; Weiss JP; Hyacinthe LM; McNeil BK; Winer AG
Int Braz J Urol; 2018; 44(4):697-703. PubMed ID: 29617073
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012.
Rezaee ME; Ward CE; Odom BD; Pollock M
Prev Med; 2016 Jan; 82():73-6. PubMed ID: 26592690
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy.
Orom H; Underwood W; Homish DL; Kiviniemi MT; Homish GG; Nelson CJ; Schiffman Z
Psychooncology; 2015 Sep; 24(9):1073-9. PubMed ID: 25382436
[TBL] [Abstract][Full Text] [Related]
20. Changing clinical trends in 10 000 robot-assisted laparoscopic prostatectomy patients and impact of the 2012 US Preventive Services Task Force's statement against PSA screening.
Onol FF; P Ganapathi H; Rogers T; Palmer K; Coughlin G; Samavedi S; Coelho R; Jenson C; Sandri M; Rocco B; Patel V
BJU Int; 2019 Dec; 124(6):1014-1021. PubMed ID: 31301265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
